ACTRN12615000829516进行中（未招募）1 期
A phase 1 study of acceptability and preferences of vaporised nicotine replacement products [18mg/mL nicotine administered by vaporisers (Innokin iTaste VV4 and Cool Fire IV)] compared to standard nicotine replacement products (gum, patch, dissolvable oral strip, mouthspray, inhalator)] or vaporised nicotine-free solution [0% nicotine] in smokers living with HIV.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •HIV Positive, currently smoking a minimum of 5 tobacco cigarettes per day, aged 18+, sufficiently proficient in English to provide informed consent and to complete questionnaires, not planning to quit smoking in the next month.
排除标准
- •Exclusion criteria includes, individuals who are;
- •* pregnant
- •* breastfeeding
- •* less than 18 years of age
- •Individuals who have any of the following will require clearance from a medical practitioner in order to enrol in the study:
- •* have had a stroke or heart attack or severe angina in the last two weeks
- •* poorly controlled high blood pressure
- •* a mental health/psychiatric condition that is being treated with anti-psychotic medication
- •* overactive thyroid
- •* adrenal gland tumour
- •* kidney or liver disease
- •* a stomach ulcer
- •* poorly controlled asthma or other throat or airway disease
- •* insulin dependent diabetes mellitus
研究者
相似试验
进行中（未招募）
Unknown
ACceptability of long-acting ART in Cognitive ImpAirment (ACACIA)People living with HIV who have a cognitive impairmentMental and Behavioural DisordersISRCTN14933807niversity of Sussex20
已完成
Unknown
A survey to assess how user-friendly is the mobile phone app created to help people quit tobaccoCTRI/2023/08/056661FTB COLAB PRIVATE LIMITED100
已完成
不适用
on-randomised pilot study of a text message self-management support programme for people with diabetesMetabolic and Endocrine - DiabetesdiabetesACTRN12615000277549Waitemata District Health Board40
尚未招募
1 期
A pilot trial to assess the effectiveness and acceptability of Acceptance and Commitment Therapy among patients with Alcohol Use Disorder registered in Drug De-addiction OPD, PGIMER, Chandigarh, 2020-2022.CTRI/2021/06/034199isha
进行中（未招募）
1 期
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiencyEUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S